Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

University of Colorado, Denver: Clinical Trials & FDA Approval Profile

University of Colorado, Denver (Global / Institutional) sponsors 115 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 63 active protocols (37 recruiting now), 32 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)13.9%
Median Closed Enrollment vs National (145 pts)31 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for University of Colorado, Denver
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)115
Active Pipeline (Recruiting Now)63 (37)
Completed vs Stopped Early32 / 16 (13.9%)
Median Closed Actual Enrollment31 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With University of Colorado, Denver
Hospital Research SiteLocationShared Protocols
University of Colorado Anschutz Medical CampusAurora, CO77
Children's Hospital ColoradoAurora, CO9
Oregon Health and Science University Knight Cancer InstitutePortland, OR3

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for UCHealth / University of Colorado across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the University of Colorado, Denver Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI